858 Therapeutics
San Diego
About 858 Therapeutics
858 Therapeutics is a biotechnology company focused on discovering small molecule therapeutics for novel targets in oncology and immunology. The company emphasizes innovative approaches in synthetic lethality, innate immunity, and RNA modulation. Its lead program is a PARG inhibitor currently in early clinical development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $130.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2024)
- Website: 8five8tx.com
- Phone: (858) 987-8380
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/858-therapeutics-49408 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.